OurCrowd (Investment in Cyto) L.P. — Form D
OurCrowd (Investment in Cyto) L.P. of JERUSALEM, L3, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2020-08-04. $285K was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2020-08-04
- Form: D
- Accession: 0001819632-20-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b
- Amount sold: $285K
- Minimum investment: $10K
- Investors: 2
- Date of first sale: 2020-07-10
- Security types: fund interests
- Revenue range: No Revenues
- SEC file number: 021-372480
Issuer
- Name: OurCrowd (Investment in Cyto) L.P.
- CIK: 0001819632
- Entity type: Limited Partnership
- Jurisdiction: VIRGIN ISLANDS, BRITISH
- Incorporated: 2019
- Address: DERECH HEBRON 28, JERUSALEM, L3, 9108001
- Phone: 00972-636-9300
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Caleb Chill | Executive Officer | Jerusalem, L3 |
| Jonathan Medved | Director | Jerusalem, L3 |
| Jonathan Medved | Executive Officer | Jerusalem, L3 |
| Robert Citron | Executive Officer | Jerusalem, L3 |
| Andrew Kaye | Director | Jerusalem, L3 |
| Andrew Kaye | Executive Officer | Jerusalem, L3 |
Other filings by this issuer (3)
More